BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16319662)

  • 1. Time course of release of inflammatory markers after coronary stenting: comparison between bare metal stent and sirolimus-eluting stent.
    Kefer JM; Galanti LM; Desmet S; Deneys V; Hanet CE
    Coron Artery Dis; 2005 Dec; 16(8):505-9. PubMed ID: 16319662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.
    Suttorp MJ; Laarman GJ; Rahel BM; Kelder JC; Bosschaert MA; Kiemeneij F; Ten Berg JM; Bal ET; Rensing BJ; Eefting FD; Mast EG
    Circulation; 2006 Aug; 114(9):921-8. PubMed ID: 16908768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.
    Valgimigli M; Percoco G; Malagutti P; Campo G; Ferrari F; Barbieri D; Cicchitelli G; McFadden EP; Merlini F; Ansani L; Guardigli G; Bettini A; Parrinello G; Boersma E; Ferrari R;
    JAMA; 2005 May; 293(17):2109-17. PubMed ID: 15870414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
    Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
    N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.
    Dibra A; Ndrepepa G; Mehilli J; Dirschinger J; Pache J; Schühlen H; Schömig A; Kastrati A
    Am J Cardiol; 2005 May; 95(10):1238-40. PubMed ID: 15878000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents.
    Gaspardone A; Versaci F; Tomai F; Citone C; Proietti I; Gioffrè G; Skossyreva O
    Am J Cardiol; 2006 May; 97(9):1311-6. PubMed ID: 16635602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of stent graft, sirolimus stent, and bare metal stent implanted in patients with acute coronary syndrome: clinical and angiographic follow-up.
    Strozzi M; Anić D
    Croat Med J; 2007 Jun; 48(3):348-52. PubMed ID: 17589978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT).
    Thuesen L; Kelbaek H; Kløvgaard L; Helqvist S; Jørgensen E; Aljabbari S; Krusell LR; Jensen GV; Bøtker HE; Saunamäki K; Lassen JF; van Weert A;
    Am Heart J; 2006 Dec; 152(6):1140-5. PubMed ID: 17161067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus.
    Nishio K; Shigemitsu M; Kodama Y; Konno N; Katagiri T; Kobayashi Y
    Cardiovasc Revasc Med; 2009; 10(1):5-11. PubMed ID: 19159848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
    Mauri L; O'Malley AJ; Popma JJ; Moses JW; Leon MB; Holmes DR; Teirstein PS; Cutlip DE; Donahoe D; Kuntz RE
    Am J Cardiol; 2005 May; 95(10):1140-5. PubMed ID: 15877983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
    Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
    JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
    Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
    Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological features of in-stent restenosis after sirolimus-eluting stent versus bare metal stent placement.
    Abe S; Yoneda S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
    Cardiovasc Pathol; 2012; 21(2):e19-22. PubMed ID: 21489821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
    Sawhney N; Moses JW; Leon MB; Kuntz RE; Popma JJ; Bachinsky W; Bass T; DeMaio S; Fry E; Holmes DR; Teirstein PS
    Circulation; 2004 Jul; 110(4):374-9. PubMed ID: 15249503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proximal left anterior descending coronary artery revascularization with drug-eluting stents.
    Guardado JH; Moreno R; Costa J; Perez-Viscayno MJ; Segura L; Alfonso F; Hernández R; Escaned J; Bañuelos C; Macaya C
    Arq Bras Cardiol; 2007 Feb; 88(2):159-66. PubMed ID: 17384832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of intimal hyperplasia after sirolimus-eluting stent and thin-strut bare-metal stent implantation in small coronary arteries].
    Devito FS; Sousa AG; Feres F; Abizaid AA; Staico R; Mattos LA; Tanajura LF; Abizaid AC; Chaves AJ; Sousa JE
    Arq Bras Cardiol; 2006 Apr; 86(4):268-75. PubMed ID: 16680291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance.
    Seung KB; Kim YH; Park DW; Lee BK; Lee CW; Hong MK; Kim PJ; Chung WS; Tahk SJ; Park SW; Park SJ
    J Am Coll Cardiol; 2005 Sep; 46(5):787-92. PubMed ID: 16139126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial].
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; Gómez-Hospital JA; Sanmartín M; Bañuelos C; Moreno R; Escaned J; Fernández C; Costa MA; Fernández-Avilés F; Macaya C
    Rev Esp Cardiol; 2006 Oct; 59(10):1000-7. PubMed ID: 17125709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.